InsiderTrades

Form 4 for PROK PROKIDNEY CORP.

Accepted 2022-07-13 00:00:00 ET · period of report 2022-07-11 · accession 0001209191-22-042045 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-07-13 2022-07-11 PROK SCS Sponsor III LLC Former Dir, 10% Owner J - Other $0.00 -6.86M 0 -100% $0
D 2022-07-13 2022-07-11 PROK SCS Sponsor III LLC Former Dir, 10% Owner M - OptEx $0.00 +6.22M 6.86M +972% $0
D 2022-07-13 2022-07-11 PROK SCS Sponsor III LLC Former Dir, 10% Owner M - OptEx $0.00 -6.22M 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A ordinary shares 2022-07-11 J D 6,860,000 $0.00 0 D — — (F3) Represents the distribution for no consideration by the Sponsor of 6,860,000 Class A ordinary shares to its members pro rata in accordance with their respective interests.
2 Common Class A ordinary shares 2022-07-11 M A 6,220,000 $0.00 6,860,000 D — — (F2) The Sponsor is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by SC SPAC Holdings LLC, the successor by merger to ChaChaCha DNA III, LLC ("SC SPAC Holdings"). Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Mehta and Cowen and SC SPAC Holdings may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. (F1) The Class B ordinary shares held by the reporting owner, SCS Sponsor III LLC (the "Sponsor"), converted to Class A ordinary shares on a one-for-one basis upon the consummation of the business combination between the issuer and ProKidney LP.
3 Derivative Class B ordinary shares 2022-07-11 M D 6,220,000 $0.00 0 D — · — to — 6,220,000 Class A ordinary shares (F2) The Sponsor is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by SC SPAC Holdings LLC, the successor by merger to ChaChaCha DNA III, LLC ("SC SPAC Holdings"). Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Mehta and Cowen and SC SPAC Holdings may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. (F1) The Class B ordinary shares held by the reporting owner, SCS Sponsor III LLC (the "Sponsor"), converted to Class A ordinary shares on a one-for-one basis upon the consummation of the business combination between the issuer and ProKidney LP. (F4) The Class B ordinary shares were automatically convertible into Class A ordinary shares at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments, and had no expiration date.